Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depression.
Johnson DE, Rodrigues NB, Weisz S, Chisamore N, Kaczmarek ES, Chen-Li DCJ, Doyle Z, Richardson JD, Mansur RB, McIntyre RS, Rosenblat JD.
Johnson DE, et al. Among authors: mcintyre rs.
Eur Neuropsychopharmacol. 2025 Feb;91:69-77. doi: 10.1016/j.euroneuro.2024.11.008. Epub 2024 Dec 5.
Eur Neuropsychopharmacol. 2025.
PMID: 39642450
Free article.
Therefore, we conducted a retrospective analysis of 134 patients from the Canadian Rapid Treatment Center of Excellence to compare the effectiveness of four ketamine infusions (0.5-0.75 mg/kg) in reducing symptoms of depression and PTSD in TRD patients with and with …
Therefore, we conducted a retrospective analysis of 134 patients from the Canadian Rapid Treatment Center of Excellence to com …